A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients - Concepedia

Concepedia

Publication | Open Access

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

DOI Full Paper Access

123

Citations

16

References

2019

Year

Yasuhiro Fujiwara, Hirofumi Mukai, Toshiaki Saeki, Jungsil Ro, Yung‐Chang Lin, Shigenori E. Nagai, Keun Seok Lee, Junichiro Watanabe, Shoichiro Ohtani, Sung Bae Kim,

British Journal of Cancer

References

	Year	Citations

Page 1